Catabasis Pharmaceuticals, Inc. Gains 28.22%

Wed, Dec 02, 2020 at 05:32 PM
Catabasis Pharmaceuticals, Inc. Gains 28.22%

Catabasis Pharmaceuticals, Inc. (CATB:NASDAQ) rocketted at $2.09, a gain of 28.2%. On Tue 01 Dec 20, CATB:NASDAQ hit a New 2-Week Intraday High of $1.75. The stock got featured on our News Catalysts scanner on Thu 12 Nov 20 at 05:57 PM in the 'INVESTOR UPDATE' category. From Tue 17 Nov 20, the stock recorded 66.67% Up Days and 60.00% Green Days

The stock spiked on Mon 24 Aug 20 at $8.59 with a volume of 1M+, and its share price has been moving sideways in recent weeks.

About Catabasis Pharmaceuticals, Inc. (CATB:NASDAQ)

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's primary focus is on treatments for rare diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.